Annals of Hematology

, Volume 92, Issue 8, pp 1023–1032 | Cite as

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review

  • Laurien A. Daniëls
  • Simone Oerlemans
  • Augustinus D. G. Krol
  • Lonneke V. van de Poll-Franse
  • Carien L. Creutzberg
Review Article

Abstract

Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long-term symptoms and is often reported to interfere with daily life. We conducted a systematic review to determine prevalence, severity and predisposing factors of fatigue in HL survivors. A literature search was conducted up to August 2012. Twenty-two articles comparing HL survivors with norm population data met all predefined selection criteria. Prevalence rates, levels of fatigue and clinical relevance of the results were determined. Prevalence of fatigue ranged from 11–76 % in HL survivors compared to 10 % in the general population. Mean fatigue scores were 5–13 % higher compared to the normative population; these findings were clinically relevant in 7 out of 11 studies. Increasing age was associated with higher levels of fatigue in HL survivors. Treatment modality and stage of initial disease were not associated with higher fatigue levels, while comorbidities or other treatment sequelae seemed to impact on the levels of fatigue. HL survivors are at serious risk for developing clinically relevant, long-term fatigue. The impact of patient and treatment characteristics on risk of fatigue is limited. Focus for future research should shift to the role of late-treatment sequelae and psychological distress symptoms.

Keywords

Hodgkin lymphoma Fatigue Vitality Health-related quality of life 

Notes

Disclosure

The authors have declared no conflicts of interest.

Supplementary material

277_2013_1793_MOESM1_ESM.doc (241 kb)
ESM 1 (DOC 241 kb)

References

  1. 1.
    De Bruin ML, Sparidans J, Van’t Veer MB et al (2009) Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27:4239–4246PubMedCrossRefGoogle Scholar
  2. 2.
    van den Belt-Dusebout AW, Aleman BM, Besseling G et al (2009) Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75:1420–1429PubMedCrossRefGoogle Scholar
  3. 3.
    Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21:3431–3439PubMedCrossRefGoogle Scholar
  4. 4.
    van den Belt-Dusebout AW, De WR, Gietema JA et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25:4370–4378PubMedCrossRefGoogle Scholar
  5. 5.
    Fobair P, Hoppe RT, Bloom J et al (1986) Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 4:805–814PubMedGoogle Scholar
  6. 6.
    Flechtner H, Ruffer JU, Henry-Amar M et al (1998) Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D’Etude des Lymphomes de L’Adulte and German Hodgkin Study Group. Ann Oncol 9(Suppl 5):147–154CrossRefGoogle Scholar
  7. 7.
    Ganz PA, Moinpour CM, Pauler DK et al (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group study 9133. J Clin Oncol 21:3512–3519PubMedCrossRefGoogle Scholar
  8. 8.
    Bloom JR, Fobair P, Gritz E et al (1993) Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 11:979–988PubMedGoogle Scholar
  9. 9.
    Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801PubMedCrossRefGoogle Scholar
  10. 10.
    Ganz PA, Bower JE (2007) Cancer related fatigue: a focus on breast cancer and Hodgkin’s disease survivors. Acta Oncologica 46:474–479PubMedCrossRefGoogle Scholar
  11. 11.
    Arden-Close E, Pacey A, Eiser C (2010) Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 51:628–640PubMedCrossRefGoogle Scholar
  12. 12.
    Roper K, McDermott K, Cooley ME et al (2009) Health-related quality of life in adults with Hodgkin’s disease: the state of the science. Cancer Nurs 32:E1–E17PubMedCrossRefGoogle Scholar
  13. 13.
    Henry-Amar M, Joly F (1996) Late complications after Hodgkin’s disease. Ann Oncol 7(Suppl 4):115–126PubMedCrossRefGoogle Scholar
  14. 14.
    Oerlemans S, Mols F, Nijziel MR et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hematol 90:993–1004PubMedCrossRefGoogle Scholar
  15. 15.
    Den Oudsten BL, Van Heck GL, De VJ (2007) The suitability of patient-based measures in the field of Parkinson’s disease: a systematic review. Mov Disord 22:1390–1401CrossRefGoogle Scholar
  16. 16.
    Mols F, Vingerhoets AJ, Coebergh JW et al (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41:2613–2619PubMedCrossRefGoogle Scholar
  17. 17.
    Cocks K, King MT, Velikova G et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29:89–96PubMedCrossRefGoogle Scholar
  18. 18.
    Ware JE, Kosinski M, Dewey J (2000) How to score version 2 of the SF-36 health survey. Quality Metric, LincolnGoogle Scholar
  19. 19.
    Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–592PubMedGoogle Scholar
  20. 20.
    Hjermstad MJ, Fossa SD, Oldervoll L et al (2005) Fatigue in long-term Hodgkin’s disease survivors: a follow-up study. J Clin Oncol 23:6587–6595PubMedCrossRefGoogle Scholar
  21. 21.
    Ng AK, Li S, Recklitis C et al (2005) A comparison between long-term survivors of Hodgkin’s disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16:1949–1955PubMedCrossRefGoogle Scholar
  22. 22.
    Ruffer JU, Flechtner H, Tralls P et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186PubMedCrossRefGoogle Scholar
  23. 23.
    Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261PubMedGoogle Scholar
  24. 24.
    Loge JH, Abrahamsen AF, Ekeberg O et al (2000) Fatigue and psychiatric morbidity among Hodgkin’s disease survivors. J Pain Symptom Manag 19:91–99CrossRefGoogle Scholar
  25. 25.
    Knobel H, Loge JH, Lund MB et al (2001) Late medical complications disease and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19:3226–3233PubMedGoogle Scholar
  26. 26.
    Khimani N, Chen YH, Mauch PM et al (2013) Influence of new late effects on quality of life over time in Hodgkin lymphoma survivors: a longitudinal survey study. Ann Oncol 24:226–230PubMedCrossRefGoogle Scholar
  27. 27.
    Hjermstad MJ, Oldervoll L, Fossa SD et al (2006) Quality of life in long-term Hodgkin’s disease survivors with chronic fatigue. Eur J Cancer 42:327–333PubMedCrossRefGoogle Scholar
  28. 28.
    Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Reduced health-related quality of life among Hodgkin’s disease survivors: a comparative study with general population norms. Ann Oncol 10:71–77PubMedCrossRefGoogle Scholar
  29. 29.
    Mols F, Vingerhoets AJJM, Coebergh JW et al (2006) Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: a population-based study. Eur J Cancer 42:2794–2801PubMedCrossRefGoogle Scholar
  30. 30.
    Wettergren L, Björkholm M, Axdorph U et al (2004) Determinants of health-related quality of life in long-term survivors of Hodgkin’s lymphoma. Quality of Life Research. An Int J Qual Life Aspects of Treat Care & Rehabil 13:1369–1379CrossRefGoogle Scholar
  31. 31.
    Oldervoll LM, Loge JH, Kaasa S et al (2007) Physical activity in Hodgkin’s lymphoma survivors with and without chronic fatigue compared with the general population—a cross-sectional study. BMC Cancer 7:210PubMedCrossRefGoogle Scholar
  32. 32.
    Joly F, HenryAmar M, Arveux P et al (1996) Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case–control study. J Clin Oncol 14:2444–2453PubMedGoogle Scholar
  33. 33.
    Gil-Fernandez JJ, Ramos C, Tamayo AT et al (2003) Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin’s disease: results of a controlled pilot study. Ann Hematol 82:14–18PubMedGoogle Scholar
  34. 34.
    van Tulder MW, Aaronson NK, Bruning PF (1994) The quality of life of long-term survivors of Hodgkin’s disease. Ann Oncol 5:153–158PubMedGoogle Scholar
  35. 35.
    Brandt J, Dietrich S, Meissner J et al (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 51:2012–2020PubMedCrossRefGoogle Scholar
  36. 36.
    Greil R, Holzner B, Kemmler G et al (1999) Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin’s disease from 1969 to 1994. Eur J Cancer 35:698–706PubMedCrossRefGoogle Scholar
  37. 37.
    Heutte N, Flechtner HH, Mounier N et al (2009) Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10:1160–1170PubMedCrossRefGoogle Scholar
  38. 38.
    Miltenyi Z, Magyari F, Simon Z et al (2010) Quality of life and fatigue in Hodgkin’s lymphoma patients. Tumori 96:594–600PubMedGoogle Scholar
  39. 39.
    Norum J, Wist EA (1996) Quality of life in survivors of Hodgkin’s disease. Qual Life Res 5:367–374PubMedCrossRefGoogle Scholar
  40. 40.
    Chalder T, Berelowitz G, Pawlikowska T et al (1993) Development of a fatigue scale. J Psychosom Res 37:147–153PubMedCrossRefGoogle Scholar
  41. 41.
    Smets EM, Garssen B, Bonke B et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRefGoogle Scholar
  42. 42.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRefGoogle Scholar
  43. 43.
    Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRefGoogle Scholar
  44. 44.
    Nyenhuis DL, Yamamoto C, Luchetta T et al (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79–86PubMedCrossRefGoogle Scholar
  45. 45.
    Abernethy AP, Zafar SY, Uronis H et al (2010) Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage 40:545–558PubMedCrossRefGoogle Scholar
  46. 46.
    Browne JP, O’Boyle CA, McGee HM et al (1997) Development of a direct weighting procedure for quality of life domains. Qual Life Res 6:301–309PubMedCrossRefGoogle Scholar
  47. 47.
    Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45:53–65PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Laurien A. Daniëls
    • 1
  • Simone Oerlemans
    • 2
    • 3
  • Augustinus D. G. Krol
    • 1
  • Lonneke V. van de Poll-Franse
    • 2
    • 3
  • Carien L. Creutzberg
    • 1
  1. 1.Departments of Clinical Oncology, K1-PLeiden University Medical CenterLeidenThe Netherlands
  2. 2.Comprehensive Cancer Centre SouthEindhovenThe Netherlands
  3. 3.Center of Research on Psychology in Somatic Diseases (CoRPS)Tilburg UniversityTilburgThe Netherlands

Personalised recommendations